Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$593M |
| 2 |
Abbott
ABT
|
+$259M |
| 3 |
AutoZone
AZO
|
+$204M |
| 4 |
AABA
Altaba Inc
AABA
|
+$186M |
| 5 |
D.R. Horton
DHI
|
+$178M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$215M |
| 2 |
Public Service Enterprise Group
PEG
|
+$211M |
| 3 |
Applied Materials
AMAT
|
+$203M |
| 4 |
Intuitive Surgical
ISRG
|
+$194M |
| 5 |
ConocoPhillips
COP
|
+$192M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.49% |
| 2 | Technology | 12.13% |
| 3 | Healthcare | 11.89% |
| 4 | Consumer Discretionary | 11.58% |
| 5 | Industrials | 10.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1501
Virtu Financial
VIRT
$5.76B
| $7.62M | 0.01% |
+416,211
| New | +$6.75M |
|
|
AVEO
1502
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $7.61M | 0.01% |
272,705
+58,884
| +28% | +$1.83M |
|
1503
iShare MSCI Eurozone ETF
EZU
$9.97B
| $7.58M | 0.01% |
+174,700
| New | +$7.59M |
|
|
TERP
1504
DELISTED
TerraForm Power, Inc
TERP
| $7.57M | 0.01% |
+633,254
| New | +$7.9M |
|
1505
Teradata
TDC
$2.55B
| $7.57M | 0.01% |
+196,788
| New | +$7.03M |
|
|
CIT
1506
DELISTED
CIT Group Inc.
CIT
| $7.55M | 0.01% |
153,466
-78,936
| -34% | -$3.83M |
|
1507
Vanguard FTSE Emerging Markets ETF
VWO
$126B
| $7.54M | 0.01% |
164,300
+135,799
| +476% | +$6.07M |
|
|
DNR
1508
DELISTED
Denbury Resources, Inc.
DNR
| $7.54M | 0.01% |
3,410,876
+2,587,244
| +314% | +$4.07M |
|
1509
Expeditors International
EXPD
$24.6B
| $7.52M | 0.01% |
+116,271
| New | +$7.13M |
|
1510
Cal-Maine
CALM
$3.93B
| $7.52M | 0.01% |
169,120
-351,600
| -68% | -$15.7M |
|
|
EGIO
1511
DELISTED
Edgio, Inc. Common Stock
EGIO
| $7.52M | 0.01% |
42,610
+21,676
| +104% | +$4.28M |
|
|
NSTG
1512
DELISTED
NanoString Technologies, Inc.
NSTG
| $7.51M | 0.01% |
1,004,986
-23,241
| -2% | -$220K |
|
|
OMN
1513
DELISTED
OMNOVA Solutions Inc.
OMN
| $7.48M | 0.01% |
747,896
+306,890
| +70% | +$3.27M |
|
1514
Renasant Corp
RNST
$3.75B
| $7.47M | 0.01% |
182,797
+134,754
| +280% | +$5.63M |
|
1515
PUT
Tractor Supply
TSCO
$18.4B
| $7.47M | 0.01% |
+500,000
| New | +$6.42M |
|
|
MRNS
1516
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $7.47M | 0.01% |
228,905
+11,923
| +5% | +$321K |
|
|
HEES
1517
DELISTED
H&E Equipment Services
HEES
| $7.47M | 0.01% |
183,691
-216,724
| -54% | -$7.42M |
|
|
BHVN
1518
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $7.46M | 0.01% |
+276,450
| New | +$7.61M |
|
|
MDP
1519
DELISTED
Meredith Corporation
MDP
| $7.43M | 0.01% |
112,514
+22,398
| +25% | +$1.35M |
|
1520
CALL
Bank of America
BAC
$437B
| $7.38M | 0.01% |
250,000
-1,000,000
| -80% | -$27.6M |
|
1521
Cleveland-Cliffs
CLF
$6.57B
| $7.34M | 0.01% |
+1,017,415
| New | +$6.77M |
|
1522
Commercial Vehicle Group
CVGI
$126M
| $7.33M | 0.01% |
685,955
+580,385
| +550% | +$5.57M |
|
|
XIFR
1523
XPLR Infrastructure LP
XIFR
$1.1B
| $7.33M | 0.01% |
170,089
+27,189
| +19% | +$1.09M |
|
1524
H.B. Fuller
FUL
$3.07B
| $7.33M | 0.01% |
136,113
-146,231
| -52% | -$8.13M |
|
|
DCM
1525
DELISTED
NTT DOCOMO, Inc.
DCM
| $7.33M | 0.01% |
308,351
+232,384
| +306% | +$5.66M |
|
Similar funds
Israel Englander's Q4 2017 Portfolio in Review
As of Q4 2017, Israel Englander held 4,357 positions worth $72.5B, up 10% from $65.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Israel Englander deployed $3.05B of net new capital in Q4 2017, opening 897 new positions and adding to 1,473 existing holdings. Its largest new stake was Viatris: 2,905,317 shares worth $123M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Honeywell, an estimated $215M trimmed.
- Israel Englander's largest Q4 2017 buy was Viatris: 2,905,317 shares worth $123M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $593M increase.
- Israel Englander's biggest Q4 2017 reduction was Honeywell, cutting an estimated $215M.
- Israel Englander fully exited Paychex in Q4 2017, selling an estimated $66.4M.
- Israel Englander's ten largest holdings make up 6.7% of its $72.5B portfolio in Q4 2017.
- Israel Englander opened 897 new positions and closed 601 in Q4 2017.
- Israel Englander's portfolio value rose 10% quarter-over-quarter to $72.5B.
Based on Millennium Management's 13F filing for Q4 2017, filed 14 Feb 2018.